Evidence (4781 claims)
Search and filter individual claims pulled from the papers. Looking for a specific finding ("what's the effect on wages?"), you're in the right place. Want to compare whole outcome categories against each other instead? Use the Evidence Explorer.
The board below groups claims two ways: by broad theme (nine paper-level topics) and by outcome category (the 34 claim-level outcomes that the Explorer and Syntheses also use).
Browse by theme
Nine broad, paper-level topics. Click one to filter the claims below.
Adoption
9875 claims
Filter claims →
Productivity
8807 claims
Filter claims →
Governance
7870 claims
Filter claims →
Human-AI Collaboration
7560 claims
Filter claims →
Org Design
4892 claims
Filter claims →
Innovation
4781 claims
Filtered →
Labor Markets
4004 claims
Filter claims →
Skills & Training
3308 claims
Filter claims →
Inequality
2332 claims
Filter claims →
Claims by outcome category
Counts by direction of finding. These are the same 34 outcome categories the Explorer compares and the Syntheses are written for. A linked row has a published synthesis.
| Outcome | Positive | Negative | Mixed | Null | Total |
|---|---|---|---|---|---|
| Other | 870 | 233 | 116 | 1066 | 2363 |
| Governance & Regulation | 976 | 451 | 218 | 133 | 1809 |
| Organizational Efficiency | 949 | 224 | 144 | 88 | 1416 |
| Technology Adoption Rate | 764 | 287 | 141 | 122 | 1325 |
| Research Productivity | 501 | 152 | 74 | 362 | 1101 |
| Output Quality | 542 | 216 | 69 | 69 | 896 |
| Decision Quality | 387 | 198 | 94 | 54 | 740 |
| Firm Productivity | 513 | 67 | 101 | 27 | 714 |
| AI Safety & Ethics | 249 | 303 | 73 | 36 | 667 |
| Market Structure | 190 | 192 | 134 | 27 | 548 |
| Task Allocation | 243 | 77 | 91 | 36 | 452 |
| Innovation Output | 291 | 33 | 55 | 20 | 401 |
| Skill Acquisition | 206 | 72 | 65 | 21 | 364 |
| Employment Level | 133 | 63 | 115 | 22 | 335 |
| Fiscal & Macroeconomic | 153 | 79 | 52 | 32 | 323 |
| Task Completion Time | 206 | 37 | 12 | 15 | 272 |
| Firm Revenue | 179 | 52 | 29 | 5 | 266 |
| Consumer Welfare | 130 | 76 | 47 | 13 | 266 |
| Inequality Measures | 48 | 137 | 51 | 6 | 242 |
| Worker Satisfaction | 101 | 81 | 25 | 13 | 220 |
| Error Rate | 84 | 110 | 11 | 5 | 210 |
| Wages & Compensation | 98 | 47 | 30 | 10 | 185 |
| Regulatory Compliance | 88 | 73 | 17 | 7 | 185 |
| Automation Exposure | 66 | 64 | 33 | 16 | 182 |
| Team Performance | 105 | 29 | 30 | 11 | 176 |
| Training Effectiveness | 109 | 22 | 14 | 21 | 168 |
| Developer Productivity | 114 | 21 | 14 | 8 | 158 |
| Job Displacement | 12 | 90 | 24 | 1 | 127 |
| Hiring & Recruitment | 57 | 9 | 9 | 5 | 80 |
| Skill Obsolescence | 6 | 56 | 9 | 1 | 72 |
| Social Protection | 43 | 17 | 8 | 2 | 70 |
| Creative Output | 35 | 21 | 9 | 4 | 70 |
| Labor Share of Income | 18 | 21 | 17 | 1 | 57 |
| Worker Turnover | 15 | 16 | — | 4 | 35 |
| Industry | — | — | — | 1 | 1 |
Innovation
Remove filter
Green financial instruments (blended finance, index insurance) and tailored finance products lower barriers to adoption but require appropriate risk assessment and product design for smallholders.
Policy review and program evaluation examples of blended finance and index insurance schemes; synthesis notes conditional success depending on product design and risk modeling.
Climate‑smart and agroecological practices enhance resilience and ecosystem services when combined with technological tools.
Synthesis and comparative analysis of ecology‑led and hybrid interventions; case studies showing improved resilience indicators (soil health, water retention, pest regulation) when ecological practices are used alongside technology.
A technology mix (precision agriculture, AI, IoT) improves input targeting (water, fertilizer, pesticides), yield forecasting, and supply‑chain efficiency.
Compiled evidence from pilot projects, case studies, and program evaluations reporting improved targeting and forecasting using precision sensors, AI models, and IoT monitoring; comparative analysis highlighting technological contributions to supply‑chain data flows.
Integrating advanced technologies (precision agriculture, AI, IoT), ecological practices (climate‑smart agriculture, agroecology), and inclusive finance can substantially raise smallholder productivity, resource efficiency, and environmental sustainability.
Synthesis of findings from empirical studies, pilot projects, case studies, and program evaluations across multiple regions; comparative analysis contrasting technology‑led, ecology‑led, and hybrid interventions. No single long‑run RCT establishes magnitude; evidence comes from multiple types of shorter‑term or context‑specific studies.
Adoption of AI in research strengthens institutional research performance and enhances global academic competitiveness.
Stated in Key Points and Implications. Presented as an implication of observed productivity gains; likely supported by case studies, institutional reports, and correlational analyses (usage logs correlated with productivity metrics) referenced in the literature synthesis, but no causal identification or sample details given in the abstract.
AI tools reduce cognitive and technical workload, enabling researchers to work more efficiently and produce higher-quality outputs.
Stated in Key Points and Main Finding. Basis appears to be aggregated empirical and experiential reports (surveys/interviews, case studies, and some task-based experiments in the literature). The paper's abstract does not provide explicit measurement or sample details.
AI tools assist across the full research lifecycle: idea generation, study design, literature review and synthesis, data management and analysis, writing/editing, publishing, communication, and compliance.
Key point asserted in the paper. Implied support comes from aggregated reports and studies of tool functionality and user reports (literature review, surveys, case studies). No specific sample or usage statistics provided in the abstract.
AI is becoming an integrated research productivity layer in universities that speeds and improves the entire scholarly workflow — from idea generation through analysis to dissemination — by lowering cognitive and technical burdens, which boosts research quality and institutional research performance.
Statement presented as the paper's main finding. Abstract summarizes "recent evidence" but does not specify original data or methods; likely based on literature synthesis (empirical studies, survey/interview work, case reports) rather than a single original dataset. No sample size, measurement definitions, or identification strategy provided in the abstract.
AI methods such as transfer learning, active learning, and Bayesian approaches improve data efficiency and uncertainty quantification in drug discovery and preclinical modeling.
Methodological literature and exemplar studies summarized in the review describing these approaches; heterogeneous examples, no quantitative synthesis.
Clear regulatory alignment (e.g., preparation of credibility plans and qualified digital endpoints) reduces regulatory uncertainty, de-risks investment, and raises adoption rates of AI tools.
Policy and regulatory framework analysis in the review; references to regulatory guidance and qualification processes (narrative, forward-looking).
Economic value from AI adoption concentrates with data-rich firms and platforms that own large, high-quality datasets and validation pipelines.
Economic analysis and theoretical arguments in the paper (narrative), supported by observed market patterns cited in the literature; no formal empirical valuation provided.
Adopting equity-by-design (including diverse, non‑European datasets and subgroup evaluation) reduces model bias and improves global generalizability of AI models.
Recommendations and examples in the review; draws on literature documenting subgroup performance differences and bias remediation strategies (narrative evidence).
AI-enabled trial innovations—such as integration with new approach methodologies (NAMs), adaptive and covariate-adjusted designs, and digital biomarkers—can reduce trial inefficiency while preserving scientific and ethical standards.
Narrative review of trial design optimization methods, examples of adaptive and covariate-adjusted analyses, and digital endpoint qualification discussions; case examples and methodological papers referenced without meta-analysis.
Synthesis-aware and physics-informed molecular design increases the downstream feasibility (synthetic accessibility and developability) of AI-designed compounds.
Methodological literature and case examples of synthesis-aware generative models and physics-informed approaches summarized in the narrative review (heterogeneous studies, no pooled estimate).
External validation, explicit applicability-domain reporting, and subgroup performance reporting improve model reliability and support regulatory alignment.
Technical best-practice recommendations and analysis of evolving regulatory frameworks discussed in the review; examples of regulatory guidance and credibility-plan concepts (narrative).
Structural prediction tools and structural-biology advances speed target validation and can accelerate target identification/validation workflows.
Discussion of structural biology datasets (cryo-EM/X-ray and predicted structures) and use cases in the narrative review; examples include use of predicted structures to inform target characterization (heterogeneous examples).
AI-assisted molecular design can improve lead/compound quality (e.g., potency, selectivity, developability) when using synthesis-aware and physics-informed approaches.
Review of method papers and case examples of synthesis-aware generative models and physics-informed neural networks in de novo design; examples drawn from cheminformatics and molecular design studies (heterogeneous, narrative).
AI can raise early-phase (e.g., Phase I/II) success rates when effectively applied with the technical and governance controls described.
Case studies and literature examples summarized in the narrative review reporting improved early-phase outcomes under AI-supported discovery programs; heterogeneous sample sizes and contexts, no aggregated effect estimate.
Artificial intelligence (AI) can materially shorten drug development timelines when models are predictive, interpretable, and integrated with causal/mechanistic priors, synthesis- and physics-aware molecular design, rigorous external validation (with defined applicability domains), and governance aligned to regulatory requirements.
Narrative synthesis and case examples from recent literature reviewed in the paper; heterogeneous studies and case reports across discovery and early development domains (no pooled/meta-analytic effect size provided).
There is a need for standards around evaluation, bias mitigation, provenance, and accountability in AI-assisted ideation and design.
Policy recommendation motivated by documented biases, errors, and provenance issues in the reviewed studies; grounded in the synthesis's critique of existing practice.
There will likely be complementarity-driven increases in demand for evaluative, integrative, and domain-expert roles (curators, synthesizers, implementation experts).
Inference from task-level studies and economic reasoning about complementarities between AI generative capability and human evaluative skills; empirical labor-market evidence is limited in the reviewed literature.
Lower search and idea-generation costs enabled by LLMs may speed early-stage R&D and increase the gross flow of candidate innovations.
Theoretical economic interpretation supported by empirical findings of increased idea volumes in experimental/field studies summarized in the review; no long-run causal firm-level evidence presented.
Generative AI accelerates early-stage hypothesis and prototype development by providing scaffolded prompts and procedural suggestions.
Applied case evidence and experimental studies summarized in the review showing reduced time or increased productivity in early-stage experimental/design tasks when using LLM assistance; no pooled effect size presented.
Empirical studies document that AI-assisted tools can help break cognitive fixation and generate cross-domain analogies.
Cited experimental tasks and lab studies in the literature showing higher incidence of analogical or cross-domain suggestions from LLMs and improvements on fixation-related task metrics; heterogeneity across tasks and measures.
Generative AI provides scaffolded, structured support that aids systematic hypothesis formation, prototyping steps, and decomposition of complex problems.
Review of design/ideation studies and applied case evidence where LLMs produced stepwise plans, decomposition prompts, or hypothesis scaffolds; evidence drawn from multiple short-term experimental and applied studies, sample sizes and exact designs vary by study.
Generative models rapidly produce many candidate ideas, analogies, and associative prompts that help overcome cognitive fixation.
Synthesis of experimental ideation and design studies reporting increases in number of ideas and examples of reduced fixation when participants used LLM outputs; heterogeneous sample sizes across cited studies (not reported in review).
Generative AI can raise per-worker productivity for tasks involving brainstorming, drafting, and prototyping, but realized gains depend on downstream filtering and implementation costs.
User studies showing higher output on specific tasks (brainstorming/drafting), combined with qualitative reports of filtering/implementation effort; many studies measure immediate task output but not net realized productivity after implementation.
Generative AI can increase creative output in both lab and field tasks as judged by external raters.
Controlled experiments and field studies reporting higher judged creativity/novelty scores for AI-assisted outputs versus controls; judged creativity/novelty is typically assessed by human raters using rubric-based scoring.
AI assistance helps people overcome fixation and produces cross-domain analogies that they might not generate alone.
Experimental studies and qualitative analyses documenting reductions in fixation effects and increases in cross-domain analogical suggestions when participants use generative models.
Generative AI supports systematic problem breakdown and early-stage prototyping, accelerating hypothesis generation and prototype development.
Field case studies of AI-supported prototyping and lab/user studies reporting reduced time-to-prototype and generated hypotheses; measures include time-to-prototype and user-reported usefulness.
Generative AI boosts ideational fluency—the quantity and diversity of ideas produced in brainstorming tasks.
Controlled experiments and user studies measuring number and diversity of ideas with and without AI assistance; typical study designs compare participant idea counts/uniqueness across conditions (note: many studies use small or convenience samples).
When used as a 'cognitive co-pilot' that expands the solution space and challenges assumptions while humans curate and evaluate, generative AI generates economic value.
Inferred from experimental and field findings showing increased idea quantity/diversity and faster prototyping combined with qualitative studies showing human curation is needed; economic interpretation drawn from the review rather than direct macroeconomic measurement.
Generative AI serves a dual cognitive role: (1) a high-volume catalyst for divergent idea generation and cross-domain analogy-making, and (2) a structured assistant for deconstructing complex problems and scaffolding hypotheses and prototypes.
Synthesis of controlled experiments, lab studies, field case studies, and qualitative analyses summarized in the review; evidence includes measures of idea fluency/diversity, examples of analogy production, and observations of AI-assisted problem decomposition in prototyping tasks. (Note: underlying studies are heterogeneous and often short-term or convenience samples.)
Policymakers and platforms should expand digital financial literacy programs, design fintech solutions with gender inclusivity, ensure explainability and fairness in AI systems, and promote targeted outreach to improve outcomes for women.
Policy recommendations derived from synthesis of reviewed evidence and identified frictions; prescriptive rather than empirically validated interventions within the paper (no RCTs of large‑scale policy rollouts reported).
AI‑driven personalization can reduce search and learning costs, changing women's participation margins and investment choices with implications for aggregate savings and asset allocation patterns.
Conceptual argument grounded in reviewed empirical studies of personalization effects and platform reports; proposed mechanisms rather than demonstrated aggregate macro outcomes (no causal macro studies presented).
Easier access to diversified, low‑cost products (ETFs, automated allocations) supports long‑term wealth accumulation and retirement readiness for investors, including women.
Theoretical linkage and cross‑sectional evidence on product adoption and portfolio composition discussed in the review; paper notes absence of long‑term causal studies directly linking fintech adoption to lifetime wealth outcomes.
Digitally delivered information, simulated investing experiences, and personalized explanations can alter perceived risk and increase women's willingness to adopt more diversified strategies.
Referenced experimental and survey studies showing changes in risk perceptions after information or simulation interventions, plus qualitative product evaluations (literature review; limited causal longitudinal evidence noted).
Targeted financial literacy apps and education reduce information frictions and can mitigate conservative investment behavior driven by knowledge gaps or higher perceived risk among women.
Review of experimental and survey evidence on financial literacy interventions and app‑based learning tools cited in the paper (mixed methods; some randomized interventions referenced but no unified longitudinal sample reported).
Robo‑advisors and AI‑based personalized recommendation tools can provide tailored portfolios and automated rebalancing that help women overcome time, knowledge, or confidence constraints.
Qualitative assessment of fintech product capabilities plus referenced experimental and survey studies on automated advice effects (literature review; product case studies rather than randomized field trials specific to women).
Digital financial technologies (online trading platforms, commission‑free brokers, fractional shares, and mobile apps) lower entry barriers and make investing more accessible to women who were previously underrepresented in markets.
Synthesis of platform feature descriptions and cross‑sectional platform usage studies cited in the literature review (observational comparisons of user demographics on retail platforms; no single pooled sample size reported).
SECaaS lowers fixed-cost barriers for firms to adopt secure cloud infrastructure and AI services, enabling smaller firms to participate in AI deployment.
Economic reasoning supported by cost–benefit analyses and surveys of adoption patterns; proposed empirical methods (cross-sectional/panel regressions) recommended to validate.
Governance and policy levers (SLAs, incident response plans, certifications, audits, regulation) are essential complements to technical security solutions.
Policy literature, industry best practices, and case studies showing improved outcomes when governance mechanisms are used alongside technical controls.
SECaaS can offer potential cost savings relative to building internal teams and tools, particularly for small and medium enterprises (SMEs).
Cost–benefit analyses and vendor pricing comparisons cited in industry reports; survey evidence on security spend allocation (heterogeneous findings across studies).
SECaaS gives firms access to specialized expertise and up-to-date threat feeds they might not maintain internally.
Vendor offerings and industry analyses; surveys reporting reliance on external expertise and threat intelligence services.
SECaaS provides scalability and rapid deployment of new defenses compared with building equivalent in‑house capabilities.
Industry reports and vendor benchmarks on deployment times and scalability; case studies and surveys of firm experiences (no single pooled sample size reported).
Processing and using 3D volumetric data requires substantial storage and GPU/TPU compute, creating demand for cloud compute services and managed ML platforms.
Authors note the resource requirements of 3D volumetric data processing as a practical consideration; general technical knowledge supports this claim though no resource-consumption measurements are provided in the paper.
The dataset and its standardization are intended to support automated segmentation, landmarking, feature extraction, and benchmarking for computer-vision and ML methods on biological 3D data.
Authors describe the acquisition and metadata design as 'automation-ready' and suitable for downstream automated/ML workflows.
Phenomic (3D scans) data are linked/paired to ongoing genome sequencing projects to create multimodal phenome–genome resources.
Paper reports links to genome projects where available and describes pairing of phenomic data with genome sequencing efforts.
Sampling is global and broadly covers ant phylogeny.
Authors state global sampling and intended phylogenetic breadth; taxonomic counts across genera/species presented to support breadth.
Legitimacy economies matter: public trust and stakeholder legitimacy influence willingness to share data and participate in collaborative research, with direct economic consequences for data‑intensive innovation.
Argument grounded in coded references to stakeholder legitimacy in the documents and theoretical literature linking legitimacy/trust to participation; the paper does not present empirical measures of trust or sharing behavior.